Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

NCT07512362 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Early Alzheimer's Disease
AD-MCI

Interventions

BIOLOGICAL: human Mesenchymal Stem Cells

Sponsor

Bernard (Barry) Baumel